RT @SFDiabete: #ATTD2022 Nous sommes seulement au début de la #bouclefermée mais les systèmes se développent rapidement. Présentation de l'étude pivot avec le pancréas bionique. https://t.co/qw1awIbbQM
SFDiabète on Twitter
“#ATTD2022 Nous sommes seulement au début de la #bouclefermée mais les systèmes se développent rapidement. Présentation de l'étude pivot avec le pancréas bionique.”
RT @minouvanos: New insulins coming up: ultra-fast working as well as concentrated insulin (U-500) for those with high insulin needs #ATTD2022https://t.co/Nw3YT50B69
Minou van Os on Twitter
“New insulins coming up: ultra-fast working as well as concentrated insulin (U-500) for those with high insulin needs #ATTD2022”
RT @Moodwife: Current systems have locked down their APIs. This reduces patient choice. Unlocking API intra-operability improves person-centric options for all #PLWD @ATTDconf #ATTD2022 @dedocDE #DeDoc#NIdochttps://t.co/FnFzEZkTGT
Dawnie on Twitter
“Current systems have locked down their APIs. This reduces patient choice. Unlocking API intra-operability improves person-centric options for all #PLWD @ATTDconf #ATTD2022 @dedocDE #DeDoc #NIdoc”
RT @CaroGoLoop: Arrived in Barcelona! Let's start with the incredible opportunity to attend #ATTD2022 and learn about new developments in #diabetes technologies! @dedocDE will launch the first #dedoc simposium at #ATTD! Make sure to join via fb or the dedoc website! https://t.co/zwbpZ82BjC
CaroGo on Twitter
“Arrived in Barcelona! Let's start with the incredible opportunity to attend #ATTD2022 and learn about new developments in #diabetes technologies! @dedocDE will launch the first #dedoc simposium at #ATTD! Make sure to join via fb or the dedoc website!”